Life Scientist > Biotechnology

Honeybee venom kills aggressive breast cancer cells

03 September, 2020 by Lauren Davis

Venom from honeybees has been found to induce cancer cell death in hard-to-treat triple-negative breast cancer, with minimal effect on healthy cells.


Precision NanoSystems NanoAssemblr Ignite for developing mRNA treatments and vaccines

01 September, 2020

The NanoAssemblr platform from Precision Nanosystems enables the rapid, reproducible and scalable manufacture of next-generation nanoparticle formulations such as lipid nanoparticles and liposomes to encapsulate a payload such as a SAM.


61medical brings Aussie medtech manufacturing onshore

28 August, 2020

The company has been launched in Queensland to help accelerate the development and commercialisation of Australian-born medical devices for the global market.


In a pinch: drug delivery through the skin

27 August, 2020

The formation of 'micropores' underneath the skin allows drugs applied on the surface to diffuse through it more easily.


New drug treatment reverses asthma symptoms in animal models

24 August, 2020

The drugs work through a mechanism that is distinct from currently prescribed medicines for asthma and chronic obstructive pulmonary disease.


Australia secures supplies of Oxford COVID-19 vaccine

19 August, 2020

The Australian Government has reached a deal that would see the University of Oxford's COVID-19 vaccine made available to all Australians for free.


Cannabinoids may affect other pharmaceuticals

18 August, 2020

Researchers have compiled a list of 57 medications that may not function as intended when used with medical cannabinoids, CBD oil or marijuana.


Drug candidate reverses memory loss in mice

17 August, 2020

A newly developed drug candidate has successfully reversed memory loss in a mouse model of inherited Alzheimer's disease.


Russia approves COVID-19 vaccine — but is it safe?

12 August, 2020 by Lauren Davis

Russian President Valdimir Putin has announced that his country has become the first in the world to grant regulatory approval to a COVID-19 vaccine.


Chloroquine does not inhibit SARS-CoV-2: study

28 July, 2020

The malaria drug chloroquine, demonstrated to inhibit SARS-CoV-2 infection of African green monkey kidney cells, is not able to prevent infection of human lung cells.


Smart nanoparticles can target lung tumours

27 July, 2020

The nanoparticles were engineered to only release their drug content upon a specific cue which is present in the tumour area.


Turmeric may have antiviral properties

23 July, 2020

Curcumin, a natural compound found in the spice turmeric, can prevent transmissible gastroenteritis virus (TGEV) from infecting cells in pigs.


Antidiabetic drug turns sugar into stool

21 July, 2020

Metformin, the most widely prescribed antidiabetic drug globally, promotes the excretion of blood sugar from the large intestine into the stool.


Remdesivir approved by TGA to treat COVID-19

14 July, 2020 by Lauren Davis

Remdesivir has been described as the most promising treatment option so far to reduce hospitalisation time for those suffering from severe SARS-Cov-2 infections.


Biomedical device developed from food industry by-products

07 July, 2020

The device comprised soy protein and chitin, which formed a matrix with a porous, interconnected microarchitecture similar to that of certain body tissues.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd